Drilon questions procurement of 'overpriced' medical supplies | Inquirer News

Drilon questions procurement of ‘overpriced’ medical supplies

/ 02:08 PM September 14, 2020

Senate Minority Leader Franklin Drilon. (Screen grab/Senate PRIB)

MANILA, Philippines — Senate Minority Leader Franklin Drilon on Monday flagged the government’s procurement of medical supplies, which he said were allegedly overpriced by P415.2 million.

During the Senate deliberations on the proposed budget of the Department of Budget and Management (DBM) for 2021, Drilon asked Budget Secretary Wendel Avisado to look into the matter.

Article continues after this advertisement

“There are a number of procurements which have raised questions because these are negotiated contracts and from our information, the prices were higher than what the private sector procured,” Drilon said.

FEATURED STORIES

“May I ask the DBM to look into these awards. The bidding was done by the [PS-DBM (Procurement Service of the DBM)],” he added.

Drilon cited as an example the contract awarded to Lifeline Diagnostics Supplies Inc. for the procurement of RNA extraction kits, which he said was allegedly overpriced by P41.2 million.

Article continues after this advertisement

Further, he said the purchase of testing kits from Pharmally Pharmaceutical Corp. was around P200 million overpriced.

Article continues after this advertisement

“The amount paid is P688 million. We have reason to believe that this is overpriced. Of course, we have not had an opportunity to go into it closely, but it would appear that it’s about P200 million overpriced,” Drilon said.

Article continues after this advertisement

The bidding for these procurements were conducted by the PS-DBM, the senator noted.

In response, Budget Undersecretary Lloyd Lao, executive director of the PS-DBM, explained that the department was only able to initially procure these medical supplies at a high price because the bidding was limited to local manufacturers.

Article continues after this advertisement

“The problem in present rules we have in bidding, we only wait for bidders to come and bid to us. If the bidders who come and bid to us are all pricing it at a higher price, then we have no choice but to buy it at a high price,” Lao told senators.

But he said that the PS-DBM eventually reached out to international manufacturers, through the country’s foreign posts, to procure medical supplies at a cheaper price.

“Because we are allowed to negotiate, we open our doors to international suppliers as well which with the help of our ambassadors from China and Singapore, we were able to get it for at least 40 to at least 50 percent cheaper than the prices we are sourcing it locally,” he added.

Drilon then asked the DBM to submit to the Senate finance committee a report containing a list of procurements where the amount paid could have been lower should the department opened up to more suppliers.

“Can you give us a written report of similar procurements where you discovered that you were able to negotiate a lower price and why the initial higher price was accepted from the suppliers. You were saying this was an emergency purchase,” the minority leader said.

“Can you just go through all of these supplies where in your judgement, we could have gotten a better deal had we applied the techniques that you later on adopted,” he added.

Lao assured the senator that the PS-DBM will submit the required report.

Aside from the procurement made by the PS-DBM, Drilon flagged the Department of Health’s purchase of universal transport medium and nasopharyngeal swabs from Biosite Medical Instruments.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

“[This is] about P174 million overpriced,” the senator said.

JE
TAGS: DBM, Nation, News, procurement

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.